Inflammatory arthritis: biologics may decrease cardiovascular events

Australian study finds association

Patients taking biologics for inflammatory arthritis may have a reduced risk of cardiovascular events (CVE) compared with those who are biologic-naive, but the effect disappears after ceasing the agents, an Australian study suggests.